EXAS – exact sciences corporation (US:NASDAQ)
Stock Stats
News
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers [Yahoo! Finance]
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups [Yahoo! Finance]
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
Exact Sciences Co. (NASDAQ: EXAS) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $60.00 price target on the stock.
Exact Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Form 4 EXACT SCIENCES CORP For: Apr 15 Filed by: Bloomer Aaron
Form 4 EXACT SCIENCES CORP For: Mar 07 Filed by: Conroy Kevin T
Form 4 EXACT SCIENCES CORP For: Feb 28 Filed by: Herriott James
Form 4 EXACT SCIENCES CORP For: Feb 28 Filed by: Conroy Kevin T
Form 4 EXACT SCIENCES CORP For: Feb 28 Filed by: Baranick Brian
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.